Pregled bibliografske jedinice broj: 1164745
Radiotherapy of prostate cancer: primary radiotherapy and radiotherapy in disease relapse
Radiotherapy of prostate cancer: primary radiotherapy and radiotherapy in disease relapse // Acta clinica Croatica. Supplement, 58 (2019), 46-59 doi:10.20471/acc.2019.58.s2.08 (domaća recenzija, pregledni rad, ostalo)
CROSBI ID: 1164745 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Radiotherapy of prostate cancer: primary radiotherapy and
radiotherapy in disease relapse
(Radiotherrapy of prostate cancer: primary radiotherapy and
radiotherapy in disease relapse)
Autori
Antunac, Katarina
Izvornik
Acta clinica Croatica. Supplement (0353-9474) 58
(2019);
46-59
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pregledni rad, ostalo
Ključne riječi
prostate cancer ; radiotherapy ; brachytherapy ; hypofractionation ; stereotactic body radiotherapy ; salvage radiotherapy
Sažetak
Radiotherapy presents one of the essential modes of treatment in patients with prostate cancer at almost any stage of the disease. it can be delivered as external beam radiotherapy, as brachytherapy or two methods combined. higher radiation doses are proven to be more effective than low doses and moderate hypofractionation with doses up to 3.4 Gy per fraction is proven equivalent to standard fractionation using 1.8- 2 Gy per fraction. Stereotactic body radiotherapy (SBRt) with doses from 3.4 to 7.25 Gy per fraction presents valuable option in certain subgroups of patients. in case of local regional disease relapse, radiotherapy is used in curative setting.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
POVEZANOST RADA
Ustanove:
Klinika za tumore,
KBC "Sestre Milosrdnice"
Profili:
Katarina Antunac
(autor)
